XML 57 R47.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION - Narrative (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Concentration Risk And Geographic Information [Line Items]    
Number of operating segments | segment 1  
Accounts receivable, net $ 790,266 $ 660,535 [1]
Sanofi    
Concentration Risk And Geographic Information [Line Items]    
Accounts receivable, net $ 135,700 $ 96,800
Credit Concentration Risk | Accounts Receivable | Customer One    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage 23.00% 20.00%
Credit Concentration Risk | Accounts Receivable | Customer Two    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage   11.00%
[1]
(1)December 31, 2024 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 24, 2025.